Skip to main content

BOOTHBAY FUND MANAGEMENT, LLC

Position in STOK — Stoke Therapeutics, Inc.

CIK 1549230 NEW YORK, NY

Position in STOK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,649,272
+$1,108,957 QoQ
Shares Held
80,968
+71.2% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#56
of 198 holders
Holding Since
Mar 2022
8 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in STOK Over Time

Shares Held

Position Value (USD)

Derivatives in STOK

reported options exposure · as of Dec 31, 2025
CallValue
$279,312
CallShares
8,800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $665,103,201 across 158 Biotechnology names. STOK ranks #57 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in STOK

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,649,272 80,968
2026-03-31 $1,540,315 47,307
2025-12-31 $279,312 8,800
2023-09-30 $39,400 10,000
2023-06-30 $463,468 43,600
2023-06-30 $150,733 14,180
2022-09-30 $833,316 64,900
2022-06-30 $2,714,166 205,463
2022-03-31 $4,324,996 205,463